🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Status
Unknown
Location
Henan cancer hospital
Start Date
2021-05-26
Trial ID
NCT04938297
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
The purpose of this study is to compare the efficacy and safety of genotype...
Status
Recruiting
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06803693
As the most common subtype of lymphoma, diffuse large B-cell lymphoma (DLBC...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2021-10-01
Trial ID
NCT05290090
Treatments Being Tested
The goal of this phase 2 trial is to test the safety and efficacy of Pola-Z...
Status
Recruiting
Location
Navy General Hospital
Start Date
2024-09-24
Trial ID
NCT06664411
This is a prospective, single center, single arm, open label study of zanub...
Status
Unknown
Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2023-10-12
Trial ID
NCT06033820
Treatments Being Tested
The objective of exploring the application of CHiR is to evaluate its thera...
Status
Recruiting
Location
The First Affiliated Hospital of Ningbo University
Start Date
2025-02-01
Trial ID
NCT06764017
Treatments Being Tested
This study is planned to prospectively evaluates the efficacy and safety of...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin 300020
Start Date
2025-12-25
Trial ID
NCT07299149